Circulating Fibroblast Growth Factor-21 Levels in Rheumatoid Arthritis: Associations with Disease Characteristics, Body Composition, and Physical Functioning

被引：0
|
作者：
Gould, Patrick [1 ]
Zemel, Babette [2 ]
Taratuta, Elena [1 ]
Baker, Joshua [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0744
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction
    Hindricks, Janka
    Ebert, Thomas
    Bachmann, Anette
    Kralisch, Susan
    Loessner, Ulrike
    Kratzsch, Juergen
    Stolzenburg, Jens-Uwe
    Dietel, Anja
    Beige, Joachim
    Anders, Matthias
    Bast, Ingolf
    Blueher, Matthias
    Stumvoll, Michael
    Fasshauer, Mathias
    CLINICAL ENDOCRINOLOGY, 2014, 80 (06) : 918 - 924
  • [22] Fibroblast growth factor-21, body composition, and insulin resistance in pre-pubertal and early pubertal males and females
    Hanks, Lynae J.
    Casazza, Krista
    Ashraf, Ambika P.
    Wallace, Stephenie
    Gutierrez, Orlando M.
    CLINICAL ENDOCRINOLOGY, 2015, 82 (04) : 550 - 556
  • [23] Novel Adipokine Fibroblast Growth Factor 21 Is Increased in Rheumatoid Arthritis
    Hulejova, H.
    Cerezo, L. Andres
    Kuklova, M.
    Pecha, O.
    Vondracek, T.
    Pavelka, K.
    Vencovsky, J.
    Haluzik, M.
    Senolt, L.
    PHYSIOLOGICAL RESEARCH, 2012, 61 (05) : 489 - 494
  • [24] Adiposity Is a Key Correlate of Circulating Fibroblast Growth Factor-21 Levels in African Males with or without Type 2 Diabetes Mellitus
    Mashili, Fredirick L.
    Ramaiya, Kaushik
    Lutale, Janet
    Njelekela, Marina
    Francis, Filbert
    Zierath, Juleen
    Krook, Anna
    JOURNAL OF OBESITY, 2018, 2018
  • [25] Influence of growth hormone on circulating fibroblast growth factor 21 levels in humans
    Lundberg, J.
    Hoybye, C.
    Krusenstjerna-Hafstrom, T.
    Bina, H. A.
    Kharitonenkov, A.
    Angelin, B.
    Rudling, M.
    JOURNAL OF INTERNAL MEDICINE, 2013, 274 (03) : 227 - 232
  • [26] Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease
    Raptis, Dimitrios
    Mantzoros, Christos S.
    Polyzos, Stergios A.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 77 - 96
  • [27] Pioglitazone Decreases Plasma Fibroblast Growth Factor-21 Levels in Patients with Type 2 Diabetes
    Mawatari, Kazutoshi
    Tahara, Nobuhiro
    Yasukawa, Hideo
    Oba, Toyoharu
    Nagata, Takanobu
    Kyogoku, Sachiko
    Ohshima, Hideki
    Minami, Tomoko
    Mizoguchi, Minori
    Sugi, Yusuke
    Adachi, Hisashi
    Imaizumi, Tsutomu
    CIRCULATION, 2012, 126 (21)
  • [28] Retrospective analysis of factors associated with serum levels of fibroblast growth factor-21 in patients with diabetes
    Ren, Fang
    Huang, Jiafang
    Dai, Tianran
    Gan, Feng
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (03) : 3258 - 3266
  • [29] Circulating levels of fibroblast growth factor 21 in early-stage diabetic kidney disease
    Esteghamati, A.
    Khandan, A.
    Momeni, A.
    Behdadnia, A.
    Ghajar, A.
    Nikdad, M. S.
    Noshad, S.
    Nakhjavani, M.
    Afarideh, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (03) : 785 - 794
  • [30] Circulating levels of fibroblast growth factor 21 in early-stage diabetic kidney disease
    A. Esteghamati
    A. Khandan
    A. Momeni
    A. Behdadnia
    A. Ghajar
    M. S. Nikdad
    S. Noshad
    M. Nakhjavani
    M. Afarideh
    Irish Journal of Medical Science (1971 -), 2017, 186 : 785 - 794
12345